C-reactive protein predicts ischaemic stroke in haemodialysis patients

International Journal of Clinical Practice

Volumn 63, Issue 2, 2009, Pages 243-248

  Chou, C Y ^b   Kuo, H L ^a   Lin, H H ^a   Liu, J S ^a   Liu, Y L ^a   Huang, C C ^a  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHINA MEDICAL UNIVERSITY BEIGANG HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ATORVASTATIN; C REACTIVE PROTEIN; FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; SIMVASTATIN; WARFARIN; BIOLOGICAL MARKER;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HEART ATRIUM FIBRILLATION; HEMODIALYSIS; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NEPHELOMETRY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; CLINICAL TRIAL; KAPLAN MEIER METHOD; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; RECEIVER OPERATING CHARACTERISTIC; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDY; STROKE;

BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; RENAL DIALYSIS; RETROSPECTIVE STUDIES; ROC CURVE; STROKE;

EID: 58449132269     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2007.01333.x     Document Type: Article

References (25)

1. Longenecker JC, Coresh J, Powe NR et al. Traditional cardiovascular disease risk factors in dialysis patients compared with the general population: the CHOICE Study. J Am Soc Nephrol 2002 13 : 1918 27.
2. Kawamura M, Fijimoto S, Hisanaga S et al. Incidence, outcome, and risk factors of cerebrovascular events in patients undergoing maintenance hemodialysis. Am J Kidney Dis 1998 31 : 991 6.
3. Iseki K, Fukiyama K. Clinical demographics and long-term prognosis after stroke in patients on chronic haemodialysis. The Okinawa Dialysis Study (OKIDS) Group. Nephrol Dial Transplant 2000 15 : 1808 13.
4. Toyoda K, Fujii K, Fujimi S et al. Stroke in patients on maintenance hemodialysis: a 22-year single-center study. Am J Kidney Dis 2005 45 : 1058 66.
5. Seliger SL, Gillen DL, Tirschwell D et al. Risk factors for incident stroke among patients with end-stage renal disease. J Am Soc Nephrol 2003 14 : 2623 31.
6. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002 105 : 1135 43.
7. Yasojima K, Schwab C, McGeer EG et al. Generation of C-reactive protein and complement components in atherosclerotic plaques. Am J Pathol 2001 158 : 1039 51.
8. Ridker PM, Cushman M, Stampfer MJ et al. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997 336 : 973 9.
9. Arenillas JF, Alvarez-Sabin J, Molina CA et al. C-reactive protein predicts further ischemic events in first-ever transient ischemic attack or stroke patients with intracranial large-artery occlusive disease. Stroke 2003 34 : 2463 8.
10. Masotti L, Ceccarelli E, Forconi S et al. Prognostic role of C-reactive protein in very old patients with acute ischaemic stroke. J Intern Med 2005 258 : 145 52.
11. Chambers JC, Eda S, Bassett P et al. C-reactive protein, insulin resistance, central obesity, and coronary heart disease risk in Indian Asians from the United Kingdom compared with European whites. Circulation 2001 104 : 145 50.
12. Hacke W, Kaste M, Fieschi C et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA 1995 274 : 1017 25.
13. Longstreth WT Jr., Bernick C, Manolio TA et al. Lacunar infarcts defined by magnetic resonance imaging of 3660 elderly people: the Cardiovascular Health Study. Arch Neurol 1998 55 : 1217 25.
14. Yeun JY, Levine RA, Mantadilok V et al. C-Reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients. Am J Kidney Dis 2000 35 : 469 76.
15. Carson JL, Duff A, Poses RM et al. Effect of anaemia and cardiovascular disease on surgical mortality and morbidity. Lancet 1996 348 : 1055 60.
16. Wiesholzer M, Harm F, Tomasec G et al. Incidence of stroke among chronic hemodialysis patients with nonrheumatic atrial fibrillation. Am J Nephrol 2001 21 : 35 9.
17. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999 340 : 115 26.
18. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999 340 : 448 54.
19. Danesh J, Collins R, Appleby P et al. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. JAMA 1998 279 : 1477 82.
20. Rost NS, Wolf PA, Kase CS et al. Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: the Framingham study. Stroke 2001 32 : 2575 9.
21. van Exel E, Gussekloo J, de Craen AJ et al. Inflammation and stroke: the Leiden 85-Plus Study. Stroke 2002 33 : 1135 8.
22. Curb JD, Abbott RD, Rodriguez BL et al. C-reactive protein and the future risk of thromboembolic stroke in healthy men. Circulation 2003 107 : 2016 20.
23. Wilson AM, Ryan MC, Boyle AJ. The novel role of C-reactive protein in cardiovascular disease: risk marker or pathogen. Int J Cardiol 2006 106 : 291 7.
24. Balk EM, Lau J, Goudas LC et al. Effects of statins on nonlipid serum markers associated with cardiovascular disease: a systematic review. Ann Intern Med 2003 139 : 670 82.
25. Briel M, Studer M, Glass TR et al. Effects of statins on stroke prevention in patients with and without coronary heart disease: a meta-analysis of randomized controlled trials. Am J Med 2004 117 : 596 606.